Ideal Power Inc (IPWR)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-14
$4.20-3.45%
Close 2026-09-15 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-14
Research Workspace
Put IPWR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Semiconductors is in supercycle. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — revenue grows towards $7M: Q2 FY26 revenue $5.8M vs $7M target.
View ThesisManagement screens weak on capital allocation, margins, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 76% growth a year, above the roughly 38% analysts expect, leaving little room for error.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 63% in its worst 12-month stretch.
View RiskIPWR's growth depends on expanding OEM offerings with B-TRAN-enabled solid-state circuit breakers. Revenue grew to $5.8 million in Q2 FY26, but it fell short of the $7 million target. The company trades at a valuation that looks expensive compared to peers, which implies a price about 93% below where it trades. The market is pricing in more growth than forecast, indicating expectations look full. A specific risk is the 22% probability of missing guidance on the next call, which could lead to a stock decline. Peer multiples imply a price about 93% below where it trades. This read is provisional.
Trailing returns as of 2026-09-15. IPWR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare IPWR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| IPWR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Semiconductors — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put IPWR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand OEM offerings with B-TRAN-enabled SSCBs
B-TRAN aligns with expanding OEM offerings for growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Secure production order(s) with lead Asia customer for SSCB products
Progress on SSCB products aligns with securing orders.
Advances: Expand OEM offerings with B-TRAN®-enabled SSCBs
Foundry deal directly supports B-TRAN expansion objective.
Advances: Expand OEM offerings with B-TRAN®-enabled SSCBs
Foundry deal directly supports B-TRAN expansion objective.
Advances: Convert sales funnel into production orders
Targets cash burn while expanding sales funnel significantly.